Literature DB >> 28870553

Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis.

Alessandro Picelli1, Gabriella Vallies2, Elena Chemello2, Paola Castellazzi2, Annalisa Brugnera2, Marialuisa Gandolfi3, Alessio Baricich4, Carlo Cisari4, Andrea Santamato5, Leopold Saltuari6, Andreas Waldner7, Nicola Smania3.   

Abstract

Spasticity is common in stroke and multiple sclerosis. To treat spasticity we have a wide range of interventions, whose application may depend not only on the severity of spasticity but also on its etiology. Consequently, a better understanding of muscle spasticity in different neurological diseases may inform clinicians as to the more appropriate therapeutic approach. Our aim was to compare the clinical and ultrasonographic features of spastic equinus in patients with chronic stroke and multiple sclerosis. Thirty-eight patients with secondary progressive multiple sclerosis and 38 chronic stroke patients with spastic equinus were evaluated at the affected ankle according to the following outcomes: modified Ashworth scale, Tardieu scale, passive range of motion, spastic gastrocnemius muscle echo intensity and thickness. Affected calf muscles tone was significantly greater in patients with chronic stroke (modified Ashworth scale P=0.008; Tardieu scale angle P=0.004) as well as spastic gastrocnemius muscle echo intensity (P<0.001). Affected ankle range of motion was significantly greater in patients with multiple sclerosis (P<0.001) as well as spastic gastrocnemius muscle thickness (medialis: P=0.003; lateralis: P=0.004). Our findings evidenced that the same pattern of spasticity (equinus foot) has some different features according to its etiology. This may help the management of spasticity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Equinus deformity; Muscle spasticity; Rehabilitation; Ultrasonography

Mesh:

Year:  2017        PMID: 28870553     DOI: 10.1016/j.jns.2017.07.026

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Localization of center of intramuscular nerve dense regions in adult anterior brachial muscles: a guide for botulinum toxin A injection to treat muscle spasticity.

Authors:  Shaohua Tang; Ming Xiaoming Zhang; Shengbo Yang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey.

Authors:  Giorgio Sandrini; A Baricich; C Cisari; Stefano Paolucci; Nicola Smania; A Picelli
Journal:  Funct Neurol       Date:  2018 Jan/Mar

3.  Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial.

Authors:  Nicoletta Cinone; Sara Letizia; Luigi Santoro; Salvatore Facciorusso; Raffaella Armiento; Alessandro Picelli; Maurizio Ranieri; Andrea Santamato
Journal:  Toxins (Basel)       Date:  2019-04-08       Impact factor: 4.546

4.  Synergic use of botulinum toxin injection and radial extracorporeal shockwave therapy in Multiple Sclerosis spasticity.

Authors:  Cinzia Marinaro; Cosimo Costantino; Oriana D'Esposito; Marianna Barletta; Angelo Indino; Gerardo De Scorpio; Antonio Ammendolia
Journal:  Acta Biomed       Date:  2021-01-28

5.  Ultrasonographic Evaluation of Botulinum Toxin Injection Site for the Medial Approach to Tibialis Posterior Muscle in Chronic Stroke Patients with Spastic Equinovarus Foot: An Observational Study.

Authors:  Alessandro Picelli; Alessio Baricich; Elena Chemello; Nicola Smania; Carlo Cisari; Marialuisa Gandolfi; Nicoletta Cinone; Maurizio Ranieri; Andrea Santamato
Journal:  Toxins (Basel)       Date:  2017-11-18       Impact factor: 4.546

6.  Research on lower extremity health in patients with multiple sclerosis: a systematic scoping review.

Authors:  Minna Stolt; Anne-Marie Laitinen; Juhani Ruutiainen; Helena Leino-Kilpi
Journal:  J Foot Ankle Res       Date:  2020-08-27       Impact factor: 2.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.